…I'm changing my sentiment on VHL after further DD - and pending more - Strauss.
I'm not at all comfortable with aspects of the Pathway deal and the way they were presented - or not presented - on Monday.
I need to be convinced about the robustness of the GGTI-2418 platform,
I need to know why a past license holder quit trialling.
If you and I were presiding over a potential blockbuster platform would we quit?
Of course, it's possible that the termination initiative was taken by Yale.
If so, why so?
Then there are funding/dilution issues.
Plenty for me/us to ponder.
I've yet to sell out.
Still awaiting outcome of IP review and Transgene/Novartis option deal.
…I'm changing my sentiment on VHL after further DD - and pending...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $46.40M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $2.318K | 83.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 504704 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 2243930 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| VHL (ASX) Chart |